Equities

Drazcanna Inc

DZCA:PKC

Drazcanna Inc

Actions
  • Price (USD)0.0565
  • Today's Change0.00 / 0.00%
  • Shares traded3.90k
  • 1 Year change--
  • Beta2.4124
Data delayed at least 15 minutes, as of Sep 17 2024 19:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

DrazCanna, Inc. is engaged in providing cannabis products. The Company's products include flowers, edibles, extracts, topicals, and cannabidiol (CBD) products. The Company's extraction processes include CBD distillation for use in a line of topicals, edibles, oils and concentrates for consumer use. Its topical products provide opportunities for skin health and pain relief, such as anti-aging, skin disorder, pain relief and wound healing.

  • Revenue in USD (TTM)2.05m
  • Net income in USD-5.71m
  • Incorporated1988
  • Employees--
  • Location
    Drazcanna IncDearborn HtsPO Box 600MIAMI 48127-0600United StatesUSA
  • Phone+1 (786) 618-1472
  • Fax+1 (404) 890-5615
  • Websitehttps://drazcanna.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Neximmune Inc0.00-20.62m348.67k6.00--0.5007-----18.59-18.590.000.660.00----0.00-140.56-115.07-224.94-165.07------------0.00------48.25---44.65--
Meso Numismatics Inc2.87m-10.15m363.63k1.00------0.1266-0.8144-0.81440.2303-2.070.5424--76.15---191.67-192.08----68.9560.24-353.35-821.490.0257-0.0755----57.49116.97-76.03--149.35--
NovAccess Global Inc0.00-1.74m441.57k1.00---------0.1193-0.11930.00-0.22460.00----0.00-1,836.30-2,185.89-------------------------177.93------
Endonovo Therapeutics Inc255.72k-4.40m444.45k0.00------1.74-0.0652-0.06520.0003-0.0720.2256-------388.54-303.26----96.2174.38-1,722.26-5,956.27---1.38----85.15---495.02------
Herborium Group, Inc.340.33k-318.65k545.97k2.00------1.60-0.3492-0.34920.3672-1.162.323.8925.94---216.97-490.56----58.3156.36-93.63-186.810.0331-39.14----19.45-18.15120.44------
Drazcanna Inc2.05m-5.71m562.15k--------0.2746-0.7024-0.70240.24920.10040.685--23.88---191.19---643.20---11.20---279.10-----33.040.2445--------------
Capstone Therapeutics Corp0.00-358.00k580.00k2.00---------6.58-38.120.00-60.700.00-------113.46141.94-199.60173.06-----------2.92--------52.46------
GlobeStar Therapeutics Corp0.00-1.98m639.61k-----------0.0023-0.00230.00-0.00150.00-------38,103.72-4,657.88-------7,790.20---2,834,410.00---21.00---------31.01------
Yield10 Bioscience Inc750.00k-12.70m650.59k29.00------0.8675-135.92-135.921.95-9.710.1697----25,862.07-287.44-91.26---108.09-----1,693.60-2,279.74---------86.67-35.94-6.55--1.84--
International Stem Cell Corp8.32m-529.00k712.39k29.00------0.0856-0.0661-0.06611.040.03551.462.5411.31286,965.50-12.02-29.22-84.86-73.8258.6259.49-8.22-21.010.4785-3.940.9254---4.78-6.8260.42---34.45--
PaxMedica Inc0.00-18.15m745.47k6.00--0.6011-----11.19-11.190.000.15940.00----0.00-474.77-755.77-781.78-------------3,015.030.00-------23.56------
VBI Vaccines Inc9.41m-83.99m745.74k131.00------0.0792-6.93-6.930.4818-0.21660.09231.4037.0571,839.70-81.40-46.58-171.57-58.62-24.06-277.46-881.79-2,755.980.2116-1.601.13--702.4020.9417.18---32.07--
Data as of Sep 17 2024. Currency figures normalised to Drazcanna Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.